ANNALS OF SAUDI MEDICINE, vol.40, no.3, pp.175-182, 2020 (SCI-Expanded)
BACKGROUND: There is limited data on the use of intravenous continuous infusion (CI) versus intravenous intermittent bolus (IB) doses of midazolam for conscious sedation in patients with chronic renal failure. Unexpected adverse events can occur in chronic renal failure patients undergoing short procedures.